Literature DB >> 7493234

The short-time effect of latanoprost on the intraocular pressure in normal pressure glaucoma.

D Kjellgren1, G Douglas, F S Mikelberg, S M Drance, A Alm.   

Abstract

Latanoprost, a prostaglandin analogue, was given topically to 20 patients with normal pressure glaucoma in a double masked randomized study. Either latanoprost 0.006% or placebo (vehicle) was administered twice a day for 14 days. Latanoprost caused a statistically significant (p < 0.001) reduction in intraocular pressure from a diurnal baseline level of 16.8 to 14.3 mmHg, as measured on day 14. Latanoprost was well tolerated.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7493234     DOI： 10.1111/j.1600-0420.1995.tb00274.x

Source DB:  PubMed          Journal:  Acta Ophthalmol Scand        ISSN： 1395-3907


  8 in total

1.  The effect of latanoprost 0.005% once daily versus 0.0015% twice daily on intraocular pressure and aqueous humour protein concentration in glaucoma patients. A randomized, double-masked comparison with timolol 0.5%.

Authors:  M Diestelhorst; S Roters; G K Krieglstein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

Review 2.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

3.  Efficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or less.

Authors:  Tadashi Nakano; Keiji Yoshikawa; Tairo Kimura; Hirotaka Suzumura; Mami Nanno; Takahiko Noro
Journal:  Jpn J Ophthalmol       Date:  2011-08-27       Impact factor: 2.447

Review 4.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2017-01-25

Review 5.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kanchan Ramchand; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2010-02-17

Review 6.  Neuroprotection for treatment of glaucoma in adults.

Authors:  Dayse F Sena; Kristina Lindsley
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

7.  Mirtogenol potentiates latanoprost in lowering intraocular pressure and improves ocular blood flow in asymptomatic subjects.

Authors:  Robert D Steigerwalt; Gianni Belcaro; Paolo Morazzoni; Ezio Bombardelli; Carolina Burki; Frank Schönlau
Journal:  Clin Ophthalmol       Date:  2010-05-14

8.  Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertension.

Authors:  Anne J Lee; Peter McCluskey
Journal:  Clin Ophthalmol       Date:  2010-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.